GOOGL vs PFE: Which Is the Better Buy?
Side-by-side comparison of Alphabet Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Alphabet Inc. · Communication Services
$317.41
-4.5% upside to fair value
Grade D
High Quality
VS
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
GOOGL |
PFE |
| Current Price |
$317.41 |
$26.91 |
| Fair Value Estimate |
$303.05 |
$35.00 |
| Upside to Fair Value |
-4.5%
|
+30.1%
|
| Market Cap |
$3,839.7B |
$153.0B |
| Forward P/E |
29.0x
|
9.5x
|
| EV / EBITDA |
21.5x
|
13.8x
|
| Price / Sales |
9.5x
|
2.4x
|
| Price / FCF |
52.4x
|
16.8x
|
| Revenue Growth YoY |
+11.3%
|
-1.6%
|
| Gross Margin |
59.7%
|
70.3%
|
| Operating Margin |
32.0%
|
24.7%
|
| Return on Equity |
35.0%
|
9.0%
|
| Dividend Yield |
0% |
6.4% |
| FCF Yield |
1.91%
|
5.9%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Alphabet Inc. operates as a global leader in internet content and information services, primarily through its dominant search engine, advertising platforms, and cloud computing services. The company benefits from durable competitive moats including browser and mobile OS dominance, strong brand recognition, and advanced AI infrastructure investments. Despite strong revenue growth of 11.3% year-ove…
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Accumulation Zones
| Metric |
GOOGL |
PFE |
| Zone Low |
$227.29 |
$25.00 |
| Zone High |
$257.59 |
$29.00 |
| In Buy Zone? |
No
|
Yes
|